Coherus Oncology, Inc. (CHRS)
1.63
-0.08
(-4.68%)
USD |
NASDAQ |
Feb 20, 16:00
1.66
+0.03
(+1.84%)
After-Hours: 20:00
Coherus Oncology Market Cap : 197.02M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Allogene Therapeutics, Inc. | 460.70M |
| Vertex Pharmaceuticals, Inc. | 121.15B |
| CorMedix, Inc. | 553.89M |
| Verastem, Inc. | 446.65M |
| Anavex Life Sciences Corp. | 381.81M |
Market Cap Related Metrics
| PS Ratio | 2.261 |
| PEG Ratio | -1.091 |
| Price to Book Value | 2.245 |
| Price | 1.63 |
| Earnings Yield | -97.28% |
| PEGY Ratio | -1.091 |